Please assess the completion status of the following clinical trial:

Trial Title: Treatment of Post Stroke Fatigue With a Wakefulness Promoting Agent

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* 18 years of age and stroke within 14 days~* Modified Rankin Scale 3 or under and Barthel 85 or over before stroke~* Person that can understand instruction and do tests and questionnaires on their own or with support~* has given informed consent~* MFI-20 score of 12 or more~* Infertile person or fertile women tested negative of pregnancy and using safe anticonception~Exclusion Criteria:~* Dementia or other neuropsychiatric disease making the person incapable of understanding instructions~* Other disease with fatigue as a known symptom~* stroke induced by trauma, infection or surgical procedure~* former drug abuse~* known contraindication to treatment with modafinil~* known active malignancy, benign intracranial tumor, subdural or epidural bleeding~* kidneydysfunction with creatinin more than 265 micromol/L or liver disease with ASAT (aspartate aminotransferase) elevated to more than 70 U/L for women or 100 U/L for men.~* allergy to project treatment~* use of benzodiazepin or antiepileptic drugs in a fixed dose. Sleeping pills not included.~* Patients threaded with ciclosporin or anti HIV medication

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- placebo (Type: PLACEBO_COMPARATOR): placebo
- Modafinil (Type: ACTIVE_COMPARATOR): Modafinil

Based on this trial design, predict the completion outcome and termination type (if applicable).